IRIS International Inc. met its guidance for its 2008 fiscal year on strong sales of its health care products. The Chatsworth-based in vitro diagnostics company reported a net income of $9 million, or $0.48 per diluted share, on revenues of $95.5 million. For the previous fiscal year the company reported a net income of $7.5 million, or $0.40 per diluted share, on revenues of $84.3 million. Guidance for the year was set at $94 million in revenues and earnings at $0.43 per diluted share. For the fourth quarter ending Dec. 31, IRIS reported a net income of $3.4 million, or $0.18 per diluted share, on revenues of $26.7 million. For the same period in the previous year, the company reported net income of $2.7 million, or $0.14 per diluted share, on revenues of $21.9 million. Nadra Kareem
